Saba Capital Management, L.P. - Nov 21, 2025 SCHEDULE 13D/A Report for abrdn Life Sciences Investors Common Shares, $0.01 par value (HQL)

Filing Manager
Saba Capital Management, L.P.
Reporting Manager
Saba Capital Management, L.P.
Security
abrdn Life Sciences Investors Common Shares, $0.01 par value
Symbol
HQL
Shares outstanding
28.9M shares
Disclosed Ownership
2.27M shares
Ownership
7.88%
Form type
SCHEDULE 13D/A
Date filed
11/24/2025, 11:36 AM
Date of event
Nov 21, 2025
Previous filing
Sep 26, 2025
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Saba Capital Management, L.P. 7.88% 2.27M 0 2.27M /s/ Michael D'Angelo General Counsel 0001510281
Boaz R. Weinstein 7.88% 2.27M 0 2.27M /s/ Michael D'Angelo Authorized Signatory 0001608233
Saba Capital Management GP, LLC 7.88% 2.27M 0 2.27M /s/ Michael D'Angelo Attorney-in-fact*